<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35776347</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1940-6029</ISSN><JournalIssue CitedMedium="Internet"><Volume>2515</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Methods in molecular biology (Clifton, N.J.)</Title><ISOAbbreviation>Methods Mol Biol</ISOAbbreviation></Journal><ArticleTitle>Modeling Axonal Degeneration Using Motor Nerve Organoids.</ArticleTitle><Pagination><StartPage>89</StartPage><EndPage>97</EndPage><MedlinePgn>89-97</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/978-1-0716-2409-8_6</ELocationID><Abstract><AbstractText>Degeneration of axons is characteristic of many devastating diseases including amyotrophic lateral sclerosis (ALS). However, lack of an in vitro neuronal culture system that mimics damages on nerves and axonal tracts hampered development of effective treatments. Here, we describe a method to model degeneration of motor neuron axons using motor nerve organoids that are formed with human induced pluripotent stem cells. In this protocol, motor neuron&#xa0;axon degeneration can be rapidly induced with chemical damages. Neuroprotective effects of compounds can be examined using the degenerated axons. This motor neuron axon bundle degeneration model should facilitate future screening for drugs against diseases affecting axon fascicles.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Siu Yu A</ForeName><Initials>SYA</Initials><AffiliationInfo><Affiliation>Institute of Industrial Science, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakanishi</LastName><ForeName>Yui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Industrial Science, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaneda</LastName><ForeName>Shohei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Industrial Science, The University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Mechanical Systems Engineering, Faculty of Engineering, Kogakuin University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikeuchi</LastName><ForeName>Yoshiho</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Industrial Science, The University of Tokyo, Tokyo, Japan. yikeuchi@iis.u-tokyo.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry and Biotechnology, School of Engineering, The University of Tokyo, Tokyo, Japan. yikeuchi@iis.u-tokyo.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for AI and Beyond, The University of Tokyo, Tokyo, Japan. yikeuchi@iis.u-tokyo.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Methods Mol Biol</MedlineTA><NlmUniqueID>9214969</NlmUniqueID><ISSNLinking>1064-3745</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009417" MajorTopicYN="Y">Nerve Tissue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009940" MajorTopicYN="N">Organoids</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Axonal degeneration</Keyword><Keyword MajorTopicYN="N">Induced pluripotent stem (iPS) cell</Keyword><Keyword MajorTopicYN="N">Microfluidic device</Keyword><Keyword MajorTopicYN="N">Motor neuron</Keyword><Keyword MajorTopicYN="N">Neurodegenerative disease</Keyword><Keyword MajorTopicYN="N">Organ-on-a-chip</Keyword><Keyword MajorTopicYN="N">Organoid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>1</Day><Hour>11</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35776347</ArticleId><ArticleId IdType="doi">10.1007/978-1-0716-2409-8_6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Patten SA, Armstrong GA, Lissouba A et al (2014) Fishing for causes and cures of motor neuron disorders. Dis Model Mech 7:799&#x2013;809</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.015719</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney EB, de Winter F, Verhaagen J (2014) ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front Neurosci 8:252</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr&#xec; MT, Valle C, Bozzo F, Cozzolino M (2015) Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS. Front Cell Neurosci 9:41. https://doi.org/10.3389/fncel.2015.00041</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00041</ArticleId><ArticleId IdType="pubmed">25741238</ArticleId><ArticleId IdType="pmc">4330888</ArticleId></ArticleIdList></Reference><Reference><Citation>Sances S, Bruijn LI, Chandran S et al (2016) Modeling ALS with motor neurons derived from human induced pluripotent stem cells. Nat Neurosci 19:542&#x2013;553. https://doi.org/10.1038/nn.4273</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4273</ArticleId><ArticleId IdType="pubmed">27021939</ArticleId><ArticleId IdType="pmc">5015775</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiyama T, Suzuki N, Ishikawa M et al (2019) Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons. EBioMedicine 45:362&#x2013;378</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.06.013</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K, Ishikawa M, Otomo A et al (2018) Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat Med 24:1579&#x2013;1589</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang C, Bourdette D, Banker G (2012) Oxidative stress inhibits axonal transport: implications for neurodegenerative diseases. Mol Neurodegener 7:29</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-29</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawada J, Kaneda S, Kirihara T et al (2017) Generation of a motor nerve organoid with human stem cell-derived neurons. Stem Cell Reports 9:1441&#x2013;1449</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.09.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers SM, Qi Y, Mica Y et al (2012) Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat Biotechnol 30:715&#x2013;720</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2249</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaki T, Chow SYA, Nakanishi Y et al (2020) Three-dimensional motor nerve organoid generation. J Vis Exp (163). https://doi.org/10.3791/61544</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>